Explore evidence

25 %The frequency of HBeAg among HIV/HBV co-infected cohort was 25%.

Nigeriahépatite B · HIV/HBV co-infectionpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 11 observations

7.4 %The prevalence of Hepatitis B surface antigenemia (HBsAg) positivity among pregnant women in Jos, Nigeria was 7.4% (241 out of 3,238) between November 1, 2017 and April 30, 2018.

Nigeriahépatite Bobserved November 1, 2017 to April 30, 2018published 2020Annals of African medicinePubMeddocument of 5 observations

14.9 %Chronic hepatitis B infection was the most prevalent complication, seen in 14.9% of the children.

Nigeriadrépanocytose · hépatite Bpublished 2021West African journal of medicinePubMeddocument of 10 observations

2.23 %The overall prevalence of HBV among full-time, newly admitted undergraduate university students in Southwestern Nigeria between 2015 and 2017 was 2.23%.

Nigeriahépatite Bobserved 2015 and 2017published 2023The Pan African medical journalPubMeddocument of 2 observations

8.1 %HBV prevalence in Nigeria was 8.1%.

Nigeriahépatite Bobserved 2018published 2025Pathogens (Basel, Switzerland)PubMeddocument of 8 observations

0.8 %Among 265 livestock handlers in Ibadan, Nigeria, 2 (0.8%) were coinfected with HIV and HBV.

Nigeriahépatite B · VIH/sidaobserved October 2016 to April 2017published 2024African health sciencesPubMeddocument of 5 observations

In this study, HBV genotype E was the most frequently identified genotype among asymptomatic carriers in Nigeria.

Nigeriahépatite Bpublished 2025Viruseseurope_pmcdocument of 6 observations

0.64 %Among HIV-positive patients in the study, the prevalence of HIV/HBV/HCV triple infection was 0.64% among females and 0% among males.

Nigeriahépatite B · hépatite C · VIH/sidaobserved 2019published 2020Journal of immunoassay & immunochemistryPubMeddocument of 9 observations

62 %In this study, the classical precore G1896A variant was identified in 26 out of 42 (62%) asymptomatic carriers.

Nigeriahépatite Bpublished 2025Viruseseurope_pmcdocument of 6 observations

33.2 %33.2% of participants had detectable HBV viral loads ≥300 copies/mL.

Nigeriahépatite Bobserved 2018published 2025Pathogens (Basel, Switzerland)PubMeddocument of 8 observations

800,000 deathsHepatitis B virus accounts for mortality of about 800,000 from liver cirrhosis and hepatocellular carcinoma.

Nigeriahépatite Bpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 11 observations

81 %In this study, 34 out of 42 (81%) asymptomatic carriers had the C1741T mutation in the BCP region.

Nigeriahépatite Bpublished 2025Viruseseurope_pmcdocument of 6 observations

4.7 %Hepatitis B seropositivity was observed in 62 (4.7%) of 1329 patients enrolled for haemodialysis between 2019 and 2022 in four public dialysis centres in Kano and Jigawa state, Northwest Nigeria.

Nigeriahépatite Bobserved 2019–2022published 2023The Nigerian postgraduate medical journalPubMeddocument of 10 observations

No evidence of HBV infection was observed in women with a history of HBV vaccination.

Nigeriahépatite Bpublished 2021Journal of environmental and public healthPubMeddocument of 4 observations

0.12 %Among 2386 initially uninfected pregnant women in Nigeria followed until delivery, the seroconversion rate for HIV-HBV dual infection was 0.12%.

Nigeriahépatite B · VIH/sidapublished 2025Antiviral therapyPubMeddocument of 7 observations

3.85 %Among pregnant women without formal education in Ejule Metropolis, the prevalence of HBV infection was 3.85%.

Nigeriahépatite Bpublished 2021Journal of environmental and public healthPubMeddocument of 4 observations

11.8 %Among PLHIV aged 51–60 years, the prevalence of HBeAg was 11.8%.

Nigeriahépatite Bpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 15 observations

13.9 %Among male PLHIV participants, the prevalence of HBsAg was 13.9%.

Nigeriahépatite Bpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 15 observations

2 %The seroprevalence of hepatitis B infection among HIV-infected children and young adults in Calabar, Nigeria was 2%.

Nigeriahépatite Bpublished 2024Journal of infection in developing countriesPubMeddocument of 5 observations

38.5 %The prevalence of BCP double substitution A1762T was 38.5% among sequenced BCP/PC gene amplicons.

Nigeriahépatite Bpublished 2023Viruseseurope_pmcdocument of 6 observationsDOI 10.3390/v15112188

7.2 %Among pregnant women in Jos, Nigeria, the prevalence of hepatitis B virus (HBV) was 7.2% among those without human immunodeficiency virus (HIV), during the period from 1 November 2017 to 30 April 2018.

Nigeriahépatite B · VIH/sidaobserved 1 November 2017 to 30 April 2018published 2021International journal of infectious diseases : IJID : official publication of the InternatPubMeddocument of 3 observations

3.85 %Among HIV-positive patients in the study, the prevalence of HIV/HBV co-infection was 3.85% among females and 2.57% among males.

Nigeriahépatite B · VIH/sidaobserved 2019published 2020Journal of immunoassay & immunochemistryPubMeddocument of 9 observations

9.8 %Among PLHIV aged 31–40 years, the prevalence of anti-HBe was 9.8%.

Nigeriahépatite Bpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 15 observations

0.6 %Dual seropositivity of anti-hepatitis C virus/hepatitis B surface antigen among pregnant women in Nigeria accounted for 0.6%.

Nigeriahépatite B · hépatite Cpublished 2021Women's health (London, England)PubMeddocument of 7 observations

8.7 %The prevalence of HBsAg among 150 PLHIV in the study was 8.7%.

Nigeriahépatite Bpublished 2021Journal of immunoassay & immunochemistryPubMeddocument of 15 observations